[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precision Peptide Company Inc (PNGAF)

Precision Peptide Company Inc (PNGAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The Precision Peptide Company Opens Nationwide Retail Sales Days After FDA Panel Backs Six of Seven Peptides Under Review

HighlightsSeven products are now in stock and available to purchase at precisionpeptidecompany.com: BPC, KPV, Ageless, Chill, Blue, Hair and The Recovery PatchThe Recovery Patch is the Company's first...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Advances First-to-Market Thymosin Alpha-1 Patch for Immune Support

HighlightsQ3/Q4 2026 is the targeted completion period for testing of The Precision Peptide Company's Thymosin Alpha-1 transdermal patch2025 research continues to evaluate Thymosin Alpha-1 for immune regulation...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Applauds FDA Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV

On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8-6 (one abstention) to recommend BPC-157 for inclusion on the Section 503A Bulks List.BPC-157 was the first of seven peptides...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch

HighlightsThe Precision Peptide Company's newly launched direct-to-consumer and telehealth platform is now available in all 50 states of the United States.100% U.S.-compounded peptide products are supported...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Inc. Receives 20,000-Unit Production Run of BPC-157 Transdermal Patches

HighlightsReceived full production run of approximately 20,000 BPC-157 transdermal patches, the Company's lead product candidatePatches are manufactured and independently tested in the United StatesMarks...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch

HighlightsThe Precision Peptide Company can now sell its peptide products directly to consumers online across all 50 U.S. states, with its consumer-facing retail telehealth website now liveThe site connects...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company's Needle-Free Recovery Patch Featured in Men's Health Magazine

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification

Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Announces Release of The Human Upgrade with Dave Asprey Episode Featuring Chief Scientific Officer Justin Kirkland

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)
The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership

HighlightsSigned an agreement with a U.S.-based prescription telehealth and infrastructure partner to support compliant prescribing, fulfillment, and delivery of the Company's peptide productsBuilds on...

BPC.CN : 0.4800 (+3.23%)
PNGAF : 0.3382 (+3.11%)

Barchart Exclusives

3 Reasons Microsoft Stock Soared After Q4 Earnings
Microsoft Q4 showed that its multibillion-dollar AI strategy is already paying off, and the best days may still be ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.